Here are five points:
1. The shares fell nearly 16.7 percent in the last four weeks.
2. AmSurg shares compared negative to the S&P 500 for the past week with a reported loss of 13.3 percent.
3. In the last four weeks, the shares have underperformed the index by 22.49 percent.
4. AmSurg’s 50-day moving average is $79.41 and 200-day moving average is $72.90.
5. The company has a market cap of approximately $3.3 billion.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
